Skip to content
Austria
-
-
-
Sanofi acquires Origimm Biotechnology to develop acne vaccine
FRANCE – Sanofi has announced the acquisition of Origimm Biotechnology, an Austrian privately held biotechnology company specializing in the discovery of virulent skin microbiome components…
-
Hyloris announces approval of novel drug for post-operation pain management
BELGIUM – Hyloris Pharmaceuticals SA, a specialty biopharmaceutical company dedicated to addressing unmet medical needs by reinventing existing medications, has announced the expansion of the…
-
Boehringer launches state-of-the-art biopharma production facility in Vienna
GERMANY – German family-owned biopharma major Boehringer Ingelheim has inaugurated a state-of-the-art biologics facility in Vienna, Austria heralding the single-largest investment in the company’s history.…